YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis

Benedikte Richter; A. Roslind; U. Hesse; J. Nordling; J.S. Johansen; T. Horn; Alastair Bierre Hansen

doi:10.1111/j.1365-2559.2010.03640.x

YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis

Benedikte Richter, A. Roslind, U. Hesse, J. Nordling, J.S. Johansen, T. Horn, Alastair Bierre Hansen

32 Citationer (Scopus)

Abstract

Aims: Bladder pain syndrome/interstitial cystitis (BPS/IC), diagnosed according to the new 2008 criteria of the European Society for the Study of Interstitial Cystitis (ESSIC), may lead to detrusor fibrosis. In some inflammatory diseases, fibrosis is related to YKL-40. The aims were to examine YKL-40 antigenic expression in bladder tissue and levels in serum and urine in BPS/IC and to evaluate whether YKL-40 could be a non-invasive, prognostic biomarker for bladder fibrogenesis and treatment intensity. Methods and results: Immunohistochemistry, immunoelectron microscopy and enzyme-linked immunosorbent assay (ELISA) analyses in 45 patients showed YKL-40 expression in detrusor mast cell granules and submucosal macrophages, and elevated YKL-40 levels in serum and urine compared to healthy individuals (median 72 versus 7 mu g/l, P <0.001). Clinicopathological parameters showed associations of detrusor fibrosis with YKL-40-positive cells (P = 0.001), mast cells (P = 0.014) and urine YKL-40 (P = 0.009). Bladder capacity correlated inversely with YKL-40-positive cells (P <0.001) and mast cells (P = 0.029). Treatment intensity was not associated with YKL-40. Conclusion: Serum and urine levels of YKL-40 may be used as non-invasive biomarkers in BPS/IC for the evaluation of bladder fibrogenesis

Originalsprog	Engelsk
Tidsskrift	Histopathology
Vol/bind	57
Udgave nummer	3
Sider (fra-til)	371-383
Antal sider	13
ISSN	0309-0167
DOI	https://doi.org/10.1111/j.1365-2559.2010.03640.x
Status	Udgivet - sep. 2010

Adgang til dokumentet

10.1111/j.1365-2559.2010.03640.x

Fingeraftryk

Dyk ned i forskningsemnerne om 'YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis'. Sammen danner de et unikt fingeraftryk.

Citationsformater

Richter, B., Roslind, A., Hesse, U., Nordling, J., Johansen, J. S., Horn, T., & Hansen, A. B. (2010). YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis. Histopathology, 57(3), 371-383. https://doi.org/10.1111/j.1365-2559.2010.03640.x

YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis. / Richter, Benedikte; Roslind, A.; Hesse, U. et al.
I: Histopathology, Bind 57, Nr. 3, 09.2010, s. 371-383.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Richter, B, Roslind, A, Hesse, U, Nordling, J, Johansen, JS, Horn, T & Hansen, AB 2010, 'YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis', Histopathology, bind 57, nr. 3, s. 371-383. https://doi.org/10.1111/j.1365-2559.2010.03640.x

Richter B, Roslind A, Hesse U, Nordling J, Johansen JS, Horn T et al. YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis. Histopathology. 2010 sep.;57(3):371-383. doi: 10.1111/j.1365-2559.2010.03640.x

@article{b366e7cb837349f8ab3292f130c8defc,

title = "YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis",

abstract = "Aims: Bladder pain syndrome/interstitial cystitis (BPS/IC), diagnosed according to the new 2008 criteria of the European Society for the Study of Interstitial Cystitis (ESSIC), may lead to detrusor fibrosis. In some inflammatory diseases, fibrosis is related to YKL-40. The aims were to examine YKL-40 antigenic expression in bladder tissue and levels in serum and urine in BPS/IC and to evaluate whether YKL-40 could be a non-invasive, prognostic biomarker for bladder fibrogenesis and treatment intensity. Methods and results: Immunohistochemistry, immunoelectron microscopy and enzyme-linked immunosorbent assay (ELISA) analyses in 45 patients showed YKL-40 expression in detrusor mast cell granules and submucosal macrophages, and elevated YKL-40 levels in serum and urine compared to healthy individuals (median 72 versus 7 g/l, P < 0.001). Clinicopathological parameters showed associations of detrusor fibrosis with YKL-40-positive cells (P = 0.001), mast cells (P = 0.014) and urine YKL-40 (P = 0.009). Bladder capacity correlated inversely with YKL-40-positive cells (P < 0.001) and mast cells (P = 0.029). Treatment intensity was not associated with YKL-40. Conclusion: Serum and urine levels of YKL-40 may be used as non-invasive biomarkers in BPS/IC for the evaluation of bladder fibrogenesis.",

author = "Benedikte Richter and A. Roslind and U. Hesse and J. Nordling and J.S. Johansen and T. Horn and Hansen, {Alastair Bierre}",

year = "2010",

month = sep,

doi = "10.1111/j.1365-2559.2010.03640.x",

language = "English",

volume = "57",

pages = "371--383",

journal = "Histopathology",

issn = "0309-0167",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis

AU - Richter, Benedikte

AU - Roslind, A.

AU - Hesse, U.

AU - Nordling, J.

AU - Johansen, J.S.

AU - Horn, T.

AU - Hansen, Alastair Bierre

PY - 2010/9

Y1 - 2010/9

N2 - Aims: Bladder pain syndrome/interstitial cystitis (BPS/IC), diagnosed according to the new 2008 criteria of the European Society for the Study of Interstitial Cystitis (ESSIC), may lead to detrusor fibrosis. In some inflammatory diseases, fibrosis is related to YKL-40. The aims were to examine YKL-40 antigenic expression in bladder tissue and levels in serum and urine in BPS/IC and to evaluate whether YKL-40 could be a non-invasive, prognostic biomarker for bladder fibrogenesis and treatment intensity. Methods and results: Immunohistochemistry, immunoelectron microscopy and enzyme-linked immunosorbent assay (ELISA) analyses in 45 patients showed YKL-40 expression in detrusor mast cell granules and submucosal macrophages, and elevated YKL-40 levels in serum and urine compared to healthy individuals (median 72 versus 7 g/l, P < 0.001). Clinicopathological parameters showed associations of detrusor fibrosis with YKL-40-positive cells (P = 0.001), mast cells (P = 0.014) and urine YKL-40 (P = 0.009). Bladder capacity correlated inversely with YKL-40-positive cells (P < 0.001) and mast cells (P = 0.029). Treatment intensity was not associated with YKL-40. Conclusion: Serum and urine levels of YKL-40 may be used as non-invasive biomarkers in BPS/IC for the evaluation of bladder fibrogenesis.

AB - Aims: Bladder pain syndrome/interstitial cystitis (BPS/IC), diagnosed according to the new 2008 criteria of the European Society for the Study of Interstitial Cystitis (ESSIC), may lead to detrusor fibrosis. In some inflammatory diseases, fibrosis is related to YKL-40. The aims were to examine YKL-40 antigenic expression in bladder tissue and levels in serum and urine in BPS/IC and to evaluate whether YKL-40 could be a non-invasive, prognostic biomarker for bladder fibrogenesis and treatment intensity. Methods and results: Immunohistochemistry, immunoelectron microscopy and enzyme-linked immunosorbent assay (ELISA) analyses in 45 patients showed YKL-40 expression in detrusor mast cell granules and submucosal macrophages, and elevated YKL-40 levels in serum and urine compared to healthy individuals (median 72 versus 7 g/l, P < 0.001). Clinicopathological parameters showed associations of detrusor fibrosis with YKL-40-positive cells (P = 0.001), mast cells (P = 0.014) and urine YKL-40 (P = 0.009). Bladder capacity correlated inversely with YKL-40-positive cells (P < 0.001) and mast cells (P = 0.029). Treatment intensity was not associated with YKL-40. Conclusion: Serum and urine levels of YKL-40 may be used as non-invasive biomarkers in BPS/IC for the evaluation of bladder fibrogenesis.

U2 - 10.1111/j.1365-2559.2010.03640.x

DO - 10.1111/j.1365-2559.2010.03640.x

M3 - Journal article

SN - 0309-0167

VL - 57

SP - 371

EP - 383

JO - Histopathology

JF - Histopathology

IS - 3

ER -